WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Medtronic pays about $700M for rights to sell Cornerstone Robotics' Sentire outside the US Globus Medical wins a CE mark for Excelsius3D five years after FDA clearance GE HealthCare software updates dropped patients from monitoring, now a Class II recall Boston Scientific pulls Imager II catheters over degrading tips and ends the product line MiniMed wins a CE mark for the Flex insulin pump ahead of its year-end target Boston Scientific restarts shipping a week after the August 25 cyberattack ArthroTAK gets a second 510(k), adding knee tenodesis to its sutureless tendon anchor Oura files S-1 for Nasdaq IPO with $1.21B in nine-month revenue and 5 million paid members FDA confirms a Class I recall of Boston Scientific Infinion CX leads after 1,081 serious injuries Medtronic pays about $700M for rights to sell Cornerstone Robotics' Sentire outside the US Globus Medical wins a CE mark for Excelsius3D five years after FDA clearance GE HealthCare software updates dropped patients from monitoring, now a Class II recall Boston Scientific pulls Imager II catheters over degrading tips and ends the product line MiniMed wins a CE mark for the Flex insulin pump ahead of its year-end target Boston Scientific restarts shipping a week after the August 25 cyberattack ArthroTAK gets a second 510(k), adding knee tenodesis to its sutureless tendon anchor Oura files S-1 for Nasdaq IPO with $1.21B in nine-month revenue and 5 million paid members FDA confirms a Class I recall of Boston Scientific Infinion CX leads after 1,081 serious injuries

The Tracker / August 2026 / K261413

510(k) cleared

EXTRON 3;EXTRON 6

DRTECH Corporation · Aug 19, 2026 · K261413

FDA cleared the EXTRON 3;EXTRON 6 from DRTECH Corporation on Aug 19, 2026 under K261413, a traditional 510(k). The device falls under product code OWB, Interventional Fluoroscopic X-Ray System, regulated at 21 CFR 892.1650 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Apr 30, 2026. The decision came 111 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for DRTECH Corporation in the last 12 months of the tracker.

Questions & Answers

What did FDA clear under K261413?

K261413 is the FDA 510(k) for EXTRON 3;EXTRON 6, submitted by DRTECH Corporation. FDA's decision date was Aug 19, 2026, under product code OWB (Interventional Fluoroscopic X-Ray System).

Who makes the EXTRON 3;EXTRON 6?

DRTECH Corporation, based in Seongnam-Si, is the applicant of record for K261413.

How long did the K261413 review take?

FDA received the submission on Apr 30, 2026 and issued its decision on Aug 19, 2026, 111 days later.

← All decisions in August 2026